China Resources Health Leverages Ecosystem of 2,000+ Enterprises to Drive Innovation Amid IPO Filing
From a trading firm on Connaught Road in Hong Kong in 1938 to a diversified industrial conglomerate currently ranked 80th on the Fortune Global 500, China Resources Group has undergone four key strategic transformations over the 82 years since its founding, remaining a dynamic force in the history of innovative development models for Chinese enterprises.
As a large industrial conglomerate that was among the early entrants into internet healthcare, China Resources has delivered impressive performance in the big health sector: its subsidiary, China Resources Pharmaceutical, holds well-known pharmaceutical brands such as 999, Shuanghe, Dong-E-E-Jiao, and Jiangzhong.It is the largest pharmaceutical distribution group in China by overall scale.; in the medical sector,China Resources Healthcare, one of the four major medical groups in China, operates the largest private healthcare institution network in the country, serving over 14.33 million patient visits annually.
Meanwhile, China Resources Healthcare’s innovative ecosystem layout is quietly unfolding.In 2016, China Resources Land established “Run Jiasu,” focusing on industrial innovation. In 2019, Run Jiasu launched a health-focused accelerator., leveraging CR Health's industrial resources and innovative DNA to provide validation scenarios and implementation demands for cutting-edge technologies.
Within China Resources Group’s business portfolio, the healthcare sector was the last to gain momentum but has since grown the fastest.
A brief review of China Resources Healthcare’s rapid expansion over the past decade reveals that, in addition to the robust resources injected by the China Resources Group at the corporate level, innovation aligned with modernization and digitalization needs has consistently served as the underlying logic driving its entry into new sectors.
2011In that year, China Resources Medical was established, with the Group entrusting it with the mission of focusing on hospital investment and operations, research and development and manufacturing of medical equipment, and healthcare-related services. At that time, the reform of state-owned enterprise hospitals had advanced into deep waters.Six Medical Companies Approved to Participate, with China Resources Healthcare Among Them, rapidly applied modern hospital governance models to the joint-stock reforms of multiple enterprise-owned hospitals, building its own brand from scratch.
5After the Chinese New Year,CR Healthcare entered Phoenix Healthcare, listed on the Hong Kong Stock Exchange, with an investment of HK$3.7 billion. By integrating the strengths of social capital in healthcare provision and the restructuring of central state-owned enterprise hospitals, it became the largest healthcare services group in Asia at that time.. Subsequently, China Resources Healthcare innovatively adopted the mainstream overseas IoT model to efficiently manage its portfolio of nearly 200 medical institutions, becoming a key participant in hospital restructuring and reorganization during the new healthcare reform era.
As the third wave of the internet arrives, CR Health’s expansion from 1 to N has been accompanied by noteworthy explorations in digital innovation.
2016Around that time, the internet healthcare sector gradually completed its early accumulation of online lightweight consultations, expanded into physical hospitals, and entered a new stage of more specialized development. According to VCBeat,In late 2016, China Resources Phoenix Healthcare Group partnered with a well-known domestic internet medical service platform to enable online appointment registration at its six affiliated hospitals and to establish an intelligent early-warning model for real-time infection monitoring at one of these hospitals, thereby taking the lead in advancing smart hospital development.
Thereafter, as internet-based medical practices extended downstream along the industrial chain,CR Sanjiu Decisively Enters the “Pharma-Insurance” Sector, Partnering with Ping An Good Doctor to Leverage the Professionalism of Internet Hospitals and the Product Advantages of Pharmaceutical Distribution Enterprises, establishing a closed-loop service from consultation and diagnosis to prescription, product delivery, and distribution.
By 2019, against the backdrop of the continuously optimizing innovation ecosystem for biopharmaceuticals in China,China Resources Life Sciences, Another Tier-1 Profit Center Under China Resources Health, Officially UnveiledVCBeat has learned that the park, located in the Daxing Biomedical Industry Base of Zhongguancun Science Park in Beijing, will primarily provide services including park construction and operation, innovation incubation, and industrial investment, focusing on key future medicine directions such as precision medicine, biotechnology, and digital health.
In 2016, at a “Mass Entrepreneurship and Innovation” event in Nanshan District, Shenzhen, China Resources Land, the flagship property development arm of China Resources Enterprise, officially launched its Run Jiasu Industry Accelerator to the public for the first time.One-stop startup acceleration resources for innovative and entrepreneurial enterprises, including themed spaces, industry matchmaking, startup services, and innovation activities。
Over the past four years,Run Acceleration has served over 400 innovative enterprises, facilitated successful connections between 54 companies and China Resources’ industrial resources, and nurtured star projects such as Extreme Vision, Wujing Innovation, Haosepai Salad, Pi, and Zuolin.. VCBeat has found that these projects share a common characteristic: they have identified their initial or most critical implementation scenarios within the industrial landscape of China Resources Group.
Runchen Accelerates Internal Scenarios
The growth of Wujing Innovation, a medical device supply chain service provider, serves as an excellent example. Originally starting as a digital retail store enterprise, Wujing Innovation attracted the attention of Run Accelerator after completing its angel financing round in 2017. Subsequently, Run Accelerator helped Wujing Innovation connect with the lifestyle scenario retail demands of residential properties, office buildings, and long-term rental apartments under China Resources Land, enabling the rapid deployment of its first-generation products and successful entry into the accelerator program.
With the support of Run Accelerator, Wujing Innovation’s supply chain solution for high-value orthopedic consumables within its product matrix has been validated within the logistics network of China Resources Pharmaceutical Commercial Group. Furthermore, products such as 24-hour unattended smart warehouses, industry big data decoding engines, and AI recognition engines have been deployed in multiple Grade A tertiary hospitals. This marks a successful transformation of the company, which centers on digital retail technologies, into the broader healthcare sector. During the COVID-19 pandemic, Run Accelerator, together with Wujing Innovation and Labpano, launched a panoramic remote promotion solution for orthopedics, timely addressing the challenges faced by orthopedic companies in conducting offline collaborative promotions, with the effectiveness affirmed by users.
For startups that have just completed their first round of financing, it is essential to curb the surge in operating costs driven by rapid project growth, identify appropriate resources to validate the commercial viability of their products and services, and secure matching external funding to support periods of low or even zero revenue., is a crucial developmental need; the absence of any one dimension may lead to startup failure.
VBInsight continuously understands and meets the real needs of startups in its industry services,Developed a unique “Industry Co-Creation” methodologyFor innovative projects joining the accelerator, the Run Accelerator operations team will systematically assess their development needs at the current stage and the potential for synergy with China Resources Group’s resources, precisely integrating group resources to support incubation.Once a startup project reaches maturity, Run Accelerator will also facilitate demand-side entities within the China Resources commercial ecosystem to procure products and services at prices slightly below market rates, or take direct equity stakes in the projects, thereby creating a complete entrepreneurial loop for the innovation teams.。
VBInsight Accelerates the "Industry Co-Creation" Methodology
Recently, VCBeat visited the Run Accelerator for Big Health. Chen Zhengqi, head of Run Accelerator for Big Health, told VCBeat that with the successive opening of new themed spaces, Run Accelerator has already established itself in four vertical sectors: proptech, mass consumer goods, fintech, and big health.Deployed 9 accelerators, covering 6 major cities including Shenzhen, Guangzhou, Xiamen, Zhuhai, Shantou, and Hong Kong。
2019In November, Run Accelerator’s Grand Health Accelerator officially opened., located in the core area of Shenzhen Nanshan Science and Technology Financial City and Shenzhen High-Tech Park, neighboring well-known technology enterprises such as Tencent, DJI Innovations, Desay, and TCL. By the end of May 2020, although the COVID-19 pandemic had hindered the real economy,The Greater Health Accelerator still achieved full occupancy across all spaces.
Internal Scenarios of the Run Accelerator for Big Health
"Regarding the initial idea of launching the Digital Health Accelerator, Chen Zhengqi told VCBeat, 'The entire team was quite hesitant.' The reason was simple: digital health projects have high professional barriers and long growth cycles. Moreover, although they had already nurtured several star projects, including potential unicorns, their experience in serving digital health projects was virtually zero."
Nevertheless, China Resources Group’s strong capabilities in the big health sector, coupled with the diversified health management demands driven by domestic consumption upgrades, have made it unwilling to abandon this field. Large-scale industry visits and project assessments were rapidly rolled out across China. This research also laid the initial foundation for the strategic direction of Run Accelerator’s Big Health Accelerator.
Research indicates that, compared to Run Accelerator’s strength in leveraging spatial upgrades to create office carriers, digital health startups have a greater demand for ample policy support and external resources to offset their prolonged growth cycles. This finding reveals a practical direction for Run Accelerator to break through the professional barriers in the digital health sector. Thus,Run Jiasu has decided to start with its core strength in industry matchmaking, leveraging China Resources’ healthcare resources to provide rich application scenarios for startup projects.。
In the following months, China Resources’ health and elderly care, medical services, and pharmaceutical sectors all joined in, serving as pilot scenarios for product validation, providing customer feedback, and bridging the gap between products and the market. This enabled innovative projects to iterate their products and services with precision and speed.
The second service provided by Run Accelerator’s Big Health Accelerator is the creation of vertical-sector venture capital and investment circles.
VCBeat believes that venture capital and investment in the big health sector differ from other fields, resembling more of a close-knit network. Gaining access to this circle can significantly enhance communication efficiency between investors and entrepreneurs. Recognizing this, Run Accelerator quickly partnered with China Resources Innovation Equity Investment Fund and the Technology Achievement Transformation Fund, both under China Resources Capital, as well as several renowned early-stage healthcare investment firms. Together, they have built an investment ecosystem that enables numerous high-quality projects to establish deeper connections with investors through activities such as roadshows, industry summits, and acceleration camps.
Furthermore, to meet the technical and regulatory approval requirements for product development in health and wellness startup projects,Run Accelerator collaborates with professional technical partners across the broader health industry chain to provide resident enterprises with a range of specialized services, including R&D, animal studies, clinical trials, and fast-track regulatory pathways.
COVID-19During the pandemic, Run Accelerator even launched a remote incubation platform to help startups seize development opportunities in a timely manner. Chen Zhengqi stated that Run Accelerator would continue to track the evolving growth needs of innovative projects, integrate resources as comprehensively as possible with an open mindset, and accelerate project growth.In early March 2020, Run Accelerator identified 34 industrial innovation needs across four key sectors—big health, proptech, big consumption, and fintech—within China Resources, releasing orders worth over RMB 100 billion and attracting more than 200 innovative enterprises to participate. By mid-June, Run Accelerator selected 15 teams from these participants, providing them with centralized opportunities for product demonstration and validation.。
In fact, for China’s domestic business ecosystem, technology incubation and industrial technology remain relatively novel concepts. Although such initiatives have blossomed in multiple regions across the country, a comprehensive operational theoretical framework has yet to be established. The youthfulness of Run Accelerator, a health-focused accelerator, presents both challenges and opportunities. We believe that in the present and near future, theories on industrial acceleration will continue to be refined through practical innovation. By adeptly identifying the genuine needs of innovative startups and rapidly mobilizing resources to meet them, Run Accelerator is poised to play an even more significant role in the wave of innovation and entrepreneurship.
